95 related articles for article (PubMed ID: 16960866)
1. NF-kB inhibition as a strategy to enhance etoposide-induced apoptosis in K562 cell line.
Morotti A; Cilloni D; Pautasso M; Messa F; Arruga F; Defilippi I; Carturan S; Catalano R; Rosso V; Chiarenza A; Taulli R; Bracco E; Rege-Cambrin G; Gottardi E; Saglio G
Am J Hematol; 2006 Dec; 81(12):938-45. PubMed ID: 16960866
[TBL] [Abstract][Full Text] [Related]
2. Cotreatment with apicidin overcomes TRAIL resistance via inhibition of Bcr-Abl signaling pathway in K562 leukemia cells.
Park SJ; Kim MJ; Kim HB; Sohn HY; Bae JH; Kang CD; Kim SH
Exp Cell Res; 2009 Jul; 315(11):1809-18. PubMed ID: 19268463
[TBL] [Abstract][Full Text] [Related]
3. [Mechanism related to inhibition of leukemia K562 cells by berbamine].
WEI YL; XU L; ZHAO XY
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2009 Jul; 38(4):387-91. PubMed ID: 19693977
[TBL] [Abstract][Full Text] [Related]
4. Platelet-activating factor induces up-regulation of antiapoptotic factors in a melanoma cell line through nuclear factor-kappaB activation.
Heon Seo K; Ko HM; Kim HA; Choi JH; Jun Park S; Kim KJ; Lee HK; Im SY
Cancer Res; 2006 May; 66(9):4681-6. PubMed ID: 16651419
[TBL] [Abstract][Full Text] [Related]
5. The multikinase inhibitor sorafenib induces apoptosis in highly imatinib mesylate-resistant bcr/abl+ human leukemia cells in association with signal transducer and activator of transcription 5 inhibition and myeloid cell leukemia-1 down-regulation.
Rahmani M; Nguyen TK; Dent P; Grant S
Mol Pharmacol; 2007 Sep; 72(3):788-95. PubMed ID: 17595328
[TBL] [Abstract][Full Text] [Related]
6. STI-571 (imatinib mesylate) enhances the apoptotic efficacy of pyrrolo-1,5-benzoxazepine-6, a novel microtubule-targeting agent, in both STI-571-sensitive and -resistant Bcr-Abl-positive human chronic myeloid leukemia cells.
Greene LM; Kelly L; Onnis V; Campiani G; Lawler M; Williams DC; Zisterer DM
J Pharmacol Exp Ther; 2007 Apr; 321(1):288-97. PubMed ID: 17202400
[TBL] [Abstract][Full Text] [Related]
7. Involvement of nuclear factor-kappa B in bcl-xL-induced interleukin 8 expression in glioblastoma.
Gabellini C; Castellini L; Trisciuoglio D; Kracht M; Zupi G; Del Bufalo D
J Neurochem; 2008 Nov; 107(3):871-82. PubMed ID: 18786178
[TBL] [Abstract][Full Text] [Related]
8. Imatinib resistance in multidrug-resistant K562 human leukemic cells.
Assef Y; Rubio F; Coló G; del Mónaco S; Costas MA; Kotsias BA
Leuk Res; 2009 May; 33(5):710-6. PubMed ID: 18977528
[TBL] [Abstract][Full Text] [Related]
9. The actinomycin D-induced apoptosis in BCR-ABL-positive K562 cells is associated with cytoplasmic translocation and cleavage of RNA helicase A.
Abdelhaleem M
Anticancer Res; 2003; 23(1A):485-90. PubMed ID: 12680254
[TBL] [Abstract][Full Text] [Related]
10. CD40 and B-cell receptor signalling induce MAPK family members that can either induce or repress Bcl-6 expression.
Batlle A; Papadopoulou V; Gomes AR; Willimott S; Melo JV; Naresh K; Lam EW; Wagner SD
Mol Immunol; 2009 May; 46(8-9):1727-35. PubMed ID: 19268365
[TBL] [Abstract][Full Text] [Related]
11. Silencing of membrane-associated sialidase Neu3 diminishes apoptosis resistance and triggers megakaryocytic differentiation of chronic myeloid leukemic cells K562 through the increase of ganglioside GM3.
Tringali C; Lupo B; Cirillo F; Papini N; Anastasia L; Lamorte G; Colombi P; Bresciani R; Monti E; Tettamanti G; Venerando B
Cell Death Differ; 2009 Jan; 16(1):164-74. PubMed ID: 18820643
[TBL] [Abstract][Full Text] [Related]
12. Sorafenib induces apoptosis specifically in cells expressing BCR/ABL by inhibiting its kinase activity to activate the intrinsic mitochondrial pathway.
Kurosu T; Ohki M; Wu N; Kagechika H; Miura O
Cancer Res; 2009 May; 69(9):3927-36. PubMed ID: 19366808
[TBL] [Abstract][Full Text] [Related]
13. Transfection of a dominant-negative mutant NF-kB inhibitor (IkBm) represses p53-dependent apoptosis in acute lymphoblastic leukemia cells: interaction of IkBm and p53.
Zhou M; Gu L; Zhu N; Woods WG; Findley HW
Oncogene; 2003 Nov; 22(50):8137-44. PubMed ID: 14603254
[TBL] [Abstract][Full Text] [Related]
14. Death receptor-4 (DR4) expression is regulated by transcription factor NF-kappaB in response to etoposide treatment.
Mendoza FJ; Ishdorj G; Hu X; Gibson SB
Apoptosis; 2008 Jun; 13(6):756-70. PubMed ID: 18421578
[TBL] [Abstract][Full Text] [Related]
15. Berberine modifies cysteine 179 of IkappaBalpha kinase, suppresses nuclear factor-kappaB-regulated antiapoptotic gene products, and potentiates apoptosis.
Pandey MK; Sung B; Kunnumakkara AB; Sethi G; Chaturvedi MM; Aggarwal BB
Cancer Res; 2008 Jul; 68(13):5370-9. PubMed ID: 18593939
[TBL] [Abstract][Full Text] [Related]
16. Curcumin synergistically augments bcr/abl phosphorothioate antisense oligonucleotides to inhibit growth of chronic myelogenous leukemia cells.
Zhang KZ; Xu JH; Huang XW; Wu LX; Su Y; Chen YZ
Acta Pharmacol Sin; 2007 Jan; 28(1):105-10. PubMed ID: 17184589
[TBL] [Abstract][Full Text] [Related]
17. Differential responses of Bcl-2 family genes to etoposide in chronic myeloid leukemia K562 cells.
Fukumi S; Horiguchi-Yamada J; Nakada S; Nagai M; Ohno T; Yamada H
Mol Cell Biochem; 2000 Mar; 206(1-2):43-50. PubMed ID: 10839193
[TBL] [Abstract][Full Text] [Related]
18. Effect of curcumin on nuclear factor kappaB signaling pathways in human chronic myelogenous K562 leukemia cells.
Reuter S; Charlet J; Juncker T; Teiten MH; Dicato M; Diederich M
Ann N Y Acad Sci; 2009 Aug; 1171():436-47. PubMed ID: 19723087
[TBL] [Abstract][Full Text] [Related]
19. Novel caffeic acid ester derivative induces apoptosis by expressing FasL and downregulating NF-KappaB: Potentiation of cell death mediated by chemotherapeutic agents.
Bose JS; Gangan V; Jain SK; Manna SK
J Cell Physiol; 2009 Mar; 218(3):653-62. PubMed ID: 19034929
[TBL] [Abstract][Full Text] [Related]
20. Imatinib-resistant K562 cells are more sensitive to celecoxib, a selective COX-2 inhibitor: role of COX-2 and MDR-1.
Arunasree KM; Roy KR; Anilkumar K; Aparna A; Reddy GV; Reddanna P
Leuk Res; 2008 Jun; 32(6):855-64. PubMed ID: 18083230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
